News Release

Children's Hospital Colorado nationally ranked as Center of Excellence for Angelman, Duplication 15q Syndromes

The Chromosome 15 and Related Disorders Clinic at Children's Hospital Colorado among two other institutions in the U.S. with this designation supporting patients with the rare and complex neurogenetic disorders

Grant and Award Announcement

Children's Hospital Colorado

AURORA, Colo. (Sept. 19, 2024) – Children’s Hospital Colorado (Children’s Colorado) today announced the Chromosome 15 and Related Disorders Clinic as a nationally ranked Center of Excellence by the Angelman Syndrome Foundation and the Dup15Q Alliance.

Angelman Syndrome (AS) is a rare and complex neurogenetic disorder which can cause multiple cognitive and developmental differences, sharing symptoms and characteristics with other disorders including epilepsy, autism and cerebral palsy. AS is caused by a loss of function in the UBE3A gene in the 15th chromosome and occurs in one in 15,000 births in the U.S., with developmental delays starting to be noticed by age six to 12 months.

While there is currently no cure for AS, the Chromosome 15 and Related Disorders Clinic at Children’s Colorado has crafted multi-disciplinary care to provide holistic support for patients. Resources for patients and their families include: neurologists, physical, occupational and speech-language therapies, genetics specialists, dieticians and more. The prestigious center of excellence designation marks Children’s Colorado as one of only three clinics in the U.S. that can provide this level of care.

“My team is so grateful for this designation and for the support from the Angelman Syndrome Foundation,” said Diana Walleigh, MD, epileptologist and Director of the Chromosome 15 and Related Disorders Clinic. “Our patients and families are amazing – there’s so much potential in each of our patients, and it’s my team’s job to help unlock that. With this new designation we are hopeful to work toward finding a potential cure for AS, through research, more therapies and more ways to support families.”

Innovative support for patients with Angelman Syndrome is not new at Children’s Colorado, it’s always evolving. 

“This designation is a reflection of years of incredible work by Dr. Walleigh and her team,” said Kevin Ess, MD, PhD, and Chief of Neurology at Children’s Colorado. “We are excited at the potential of what our team can accomplish in the future with this new support.”

To learn more about the resources provided by the Chromosome 15 and Related Disorders Clinic at Children’s Colorado, please visit our website.

###

ABOUT CHILDREN’S HOSPITAL COLORADO

Children’s Hospital Colorado is one of the nation’s leading and most expansive nonprofit pediatric healthcare systems with a mission to improve the health of children through patient care, education, research and advocacy. Founded in 1908 and ranked among the best children’s hospitals in the nation as recognized by U.S. News & World Report, Children’s Colorado has established itself as a pioneer in the discovery of innovative and groundbreaking treatments that are shaping the future of pediatric healthcare worldwide. Children’s Colorado offers a full spectrum of family-centered care at its urgent, emergency and specialty care locations throughout Colorado, including an academic medical center on the Anschutz Medical Campus in Aurora, hospitals in Colorado Springs, Highlands Ranch and Broomfield, and outreach clinics across the region. For more information, visit www.childrenscolorado.org or connect with us on FacebookInstagram and YouTube.  

 

Children’s Hospital Colorado complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex.

ATENCIÓN: si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 1-720-777-9800.

CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số 1-720-777-9800.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.